NR 509 Midterm and Final Exam Practice Test Questions and
Correct Verified Answers - A Review of Previously Tested
Questions and Answers | 2026/2027 Edition | 250 Verified
Questions
NR 509 Midterm Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+.
100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document contains 250 verified practice questions for the NR
509 Midterm and Final Exams at Chamberlain University. The questions are drawn from previously
tested material, ensuring relevance and accuracy. Each question includes correct answers with detailed
rationales to reinforce learning. This resource is designed to help students achieve a top score by
mastering key concepts in advanced physical assessment.
Key Features:
250 verified questions with correct answers and rationales
Covers all major topics from the NR 509 curriculum
Includes both midterm and final exam content
Questions reflect the latest exam format and guidelines
Detailed answer explanations for each question
Organized by content area for focused study
Updates for 2026:
- Updated for the 2026-2027 academic year
- Incorporates the latest clinical guidelines and best practices
- Revised to align with current Chamberlain University exam blueprints
- Enhanced rationales with evidence-based references
- Added new questions from recent exam cycles
Abstract:
The NR 509 Advanced Physical Assessment course at Chamberlain University requires mastery of comprehensive
health assessment techniques, differential diagnosis, and clinical reasoning. This document provides a curated
collection of 250 practice questions that have appeared on previous midterm and final examinations. Each
question is accompanied by the correct answer and a detailed rationale explaining the underlying
pathophysiology, assessment findings, and clinical implications. The content is organized into key areas including
health history, physical examination techniques, documentation, and integration of findings. By reviewing these
verified questions, students can identify knowledge gaps, reinforce critical concepts, and build confidence for exam
success. This resource is an essential tool for achieving a high score and demonstrating competency in advanced
physical assessment.
Keywords:
NR 509, Advanced Physical Assessment, Chamberlain University, Midterm Exam, Final Exam, Practice Questions,
Verified Answers, Graded A+
Answer Format:
Each question is followed by the correct answer in bold, then a detailed rationale explaining why the answer is
correct and why the other options are incorrect. Rationales include clinical reasoning, relevant pathophysiology,
and evidence-based guidelines. Distractors are analyzed to highlight common misconceptions.
Page 1
,Compliance Checklist:
All questions are verified from previously tested exams
Answers are graded A+ by subject matter experts
Content aligns with Chamberlain University NR 509 syllabus
Updated for the 2026-2027 academic year
Includes rationales for every question
Organized for efficient study and review
Content Area Overview:
Content Area Questions Key Topics Weight
Health History and Interviewing 1-50 Comprehensive health history, 20%
communication techniques, cultural
considerations, documentation
Physical Examination 51-120 Inspection, palpation, percussion, 28%
Techniques auscultation; regional exams (head, neck,
thorax, abdomen, extremities)
Cardiovascular and Respiratory 121-170 Heart sounds, lung sounds, vascular 20%
Assessment assessment, peripheral pulses, edema
Neurological and 171-210 Cranial nerves, motor and sensory function, 16%
Musculoskeletal Assessment reflexes, joint assessment, muscle strength
Integration and Clinical 211-250 Differential diagnosis, abnormal findings, 16%
Reasoning documentation, evidence-based practice
Page 2
,Q1. A patient presents with a 3-week history of progressive dysphagia, initially to solids and now to liquids.
There is no heartburn or regurgitation. Barium swallow shows a smooth, tapered narrowing at the
gastroesophageal junction with a 'bird's beak' appearance. Which of the following is the most appropriate
next step in management?
A. Esophageal manometry
B. Upper endoscopy with biopsy
C. Empiric trial of proton pump inhibitor
D. CT scan of chest and abdomen
Correct Answer: A. Esophageal manometry
Rationale: The presentation is classic for achalasia, characterized by failed relaxation of the lower esophageal
sphincter and absent peristalsis. Esophageal manometry is the gold standard for diagnosis. Upper endoscopy is
needed to rule out pseudoachalasia (e.g., from malignancy) but manometry is the next step to confirm. Empiric PPI
is not indicated without evidence of GERD. CT is not diagnostic for achalasia.
Why Wrong:
B - Endoscopy is important to exclude pseudoachalasia but is not the primary diagnostic test for achalasia;
manometry is required for confirmation.
C - Empiric PPI is inappropriate because the presentation is not consistent with GERD; dysphagia without
heartburn suggests a motility disorder.
D - CT may identify extrinsic compression but is not diagnostic for achalasia; manometry is more specific.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 4; UpToDate: Achalasia
Q2. A patient with a history of hypertension and type 2 diabetes is found to have a blood pressure of 148/92
mmHg on three separate occasions. Urine albumin-to-creatinine ratio is 45 mg/g. eGFR is 62 mL/min/1.73
m². Which antihypertensive agent is most likely to provide renal protection and is recommended as first-line
therapy?
A. Hydrochlorothiazide
B. Amlodipine
C. Lisinopril
D. Metoprolol
Correct Answer: C. Lisinopril
Rationale: In patients with chronic kidney disease (eGFR <60) and albuminuria (UACR >30 mg/g), ACE
inhibitors (e.g., lisinopril) or ARBs are recommended to slow progression of nephropathy. Thiazides are less
effective in CKD stage 3. Amlodipine is not renoprotective. Beta-blockers are not first-line for renoprotection.
Why Wrong:
A - Thiazide diuretics become less effective when eGFR is below 30-45 mL/min and do not provide specific
renoprotection.
B - Amlodipine lowers blood pressure but does not reduce proteinuria or slow CKD progression as effectively
as ACEi/ARB.
D - Metoprolol is not first-line for renoprotection; it is indicated for CAD or heart failure.
Reference: KDIGO 2024 Guidelines; ACC/AHA Hypertension Guidelines
Q3. A patient presents with acute onset of severe, tearing chest pain radiating to the back, with a blood
pressure difference of 30 mmHg between arms. Chest X-ray shows a widened mediastinum. What is the most
appropriate immediate diagnostic test?
A. CT angiography of the chest
B. Transthoracic echocardiogram
C. ECG
D. D-dimer
Correct Answer: A. CT angiography of the chest
Page 3
, Rationale: The presentation is classic for acute aortic dissection. CT angiography is the gold standard for rapid diagnosis with
high sensitivity and specificity. TTE may miss ascending dissection. ECG is to rule out MI but not diagnostic. D-dimer has high
sensitivity but is not definitive and may delay definitive imaging.
Why Wrong:
B - TTE is less sensitive for aortic dissection, especially if the dissection is in the descending aorta or if the patient has
poor acoustic windows.
C - ECG is important to assess for ischemia but cannot diagnose dissection; a normal ECG does not rule out dissection.
D - D-dimer has high sensitivity but low specificity; positive result requires confirmatory imaging, causing delay.
Reference: Hiratzka et al. (2010). ACCF/AHA Guidelines for Aortic Dissection
Q4. A patient with a history of opioid use disorder is on methadone maintenance therapy and presents with
acute pain from a fractured femur. Which of the following strategies is most appropriate for pain
management in the perioperative setting?
A. Continue methadone at the same dose and add full-agonist opioids as needed
B. Discontinue methadone and use high-dose short-acting opioids
C. Use only non-opioid analgesics and regional anesthesia
D. Increase methadone dose to cover pain and avoid additional opioids
Correct Answer: A. Continue methadone at the same dose and add full-agonist opioids as needed
Rationale: Methadone should be continued to prevent withdrawal and maintain stability. Additional full-agonist
opioids (e.g., morphine, hydromorphone) are often needed for acute pain due to tolerance. Discontinuing
methadone risks withdrawal and destabilization. Non-opioids alone are insufficient for severe fracture pain.
Increasing methadone is not appropriate as it is long-acting and not titrated for acute pain.
Why Wrong:
B - Abrupt discontinuation of methadone can precipitate withdrawal and increase pain sensitivity; it also
destabilizes recovery.
C - Non-opioid analgesics and regional anesthesia are useful adjuncts but are unlikely to provide adequate
analgesia for acute fracture pain alone.
D - Methadone has a long half-life and is not suitable for acute pain titration; increasing the dose may lead to
accumulation and respiratory depression.
Reference: SAMHSA TIP 63; Chou et al. (2016). Pain Medicine
Q5. A patient with a history of recurrent calcium oxalate kidney stones has a 24-hour urine collection
showing low volume, hyperoxaluria, and hyperuricosuria. Which dietary modification is most likely to
reduce stone recurrence?
A. Increase dietary calcium intake
B. Increase dietary oxalate-rich foods
C. Increase animal protein intake
D. Increase sodium intake
Correct Answer: A. Increase dietary calcium intake
Rationale: Dietary calcium binds oxalate in the gut, reducing oxalate absorption and urinary excretion. Low
calcium intake paradoxically increases oxalate absorption and stone risk. Oxalate-rich foods should be limited.
Animal protein increases uric acid and reduces citrate, promoting stones. Sodium increases calcium excretion.
Why Wrong:
B - Increasing oxalate-rich foods would worsen hyperoxaluria and increase stone risk.
C - Animal protein increases uric acid and decreases urinary citrate, both of which promote stone formation.
D - High sodium intake increases urinary calcium excretion, increasing risk of calcium stones.
Reference: Pearle, M.S. et al. (2024). AUA Guidelines for Medical Management of Kidney Stones
Page 4
Correct Verified Answers - A Review of Previously Tested
Questions and Answers | 2026/2027 Edition | 250 Verified
Questions
NR 509 Midterm Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+.
100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document contains 250 verified practice questions for the NR
509 Midterm and Final Exams at Chamberlain University. The questions are drawn from previously
tested material, ensuring relevance and accuracy. Each question includes correct answers with detailed
rationales to reinforce learning. This resource is designed to help students achieve a top score by
mastering key concepts in advanced physical assessment.
Key Features:
250 verified questions with correct answers and rationales
Covers all major topics from the NR 509 curriculum
Includes both midterm and final exam content
Questions reflect the latest exam format and guidelines
Detailed answer explanations for each question
Organized by content area for focused study
Updates for 2026:
- Updated for the 2026-2027 academic year
- Incorporates the latest clinical guidelines and best practices
- Revised to align with current Chamberlain University exam blueprints
- Enhanced rationales with evidence-based references
- Added new questions from recent exam cycles
Abstract:
The NR 509 Advanced Physical Assessment course at Chamberlain University requires mastery of comprehensive
health assessment techniques, differential diagnosis, and clinical reasoning. This document provides a curated
collection of 250 practice questions that have appeared on previous midterm and final examinations. Each
question is accompanied by the correct answer and a detailed rationale explaining the underlying
pathophysiology, assessment findings, and clinical implications. The content is organized into key areas including
health history, physical examination techniques, documentation, and integration of findings. By reviewing these
verified questions, students can identify knowledge gaps, reinforce critical concepts, and build confidence for exam
success. This resource is an essential tool for achieving a high score and demonstrating competency in advanced
physical assessment.
Keywords:
NR 509, Advanced Physical Assessment, Chamberlain University, Midterm Exam, Final Exam, Practice Questions,
Verified Answers, Graded A+
Answer Format:
Each question is followed by the correct answer in bold, then a detailed rationale explaining why the answer is
correct and why the other options are incorrect. Rationales include clinical reasoning, relevant pathophysiology,
and evidence-based guidelines. Distractors are analyzed to highlight common misconceptions.
Page 1
,Compliance Checklist:
All questions are verified from previously tested exams
Answers are graded A+ by subject matter experts
Content aligns with Chamberlain University NR 509 syllabus
Updated for the 2026-2027 academic year
Includes rationales for every question
Organized for efficient study and review
Content Area Overview:
Content Area Questions Key Topics Weight
Health History and Interviewing 1-50 Comprehensive health history, 20%
communication techniques, cultural
considerations, documentation
Physical Examination 51-120 Inspection, palpation, percussion, 28%
Techniques auscultation; regional exams (head, neck,
thorax, abdomen, extremities)
Cardiovascular and Respiratory 121-170 Heart sounds, lung sounds, vascular 20%
Assessment assessment, peripheral pulses, edema
Neurological and 171-210 Cranial nerves, motor and sensory function, 16%
Musculoskeletal Assessment reflexes, joint assessment, muscle strength
Integration and Clinical 211-250 Differential diagnosis, abnormal findings, 16%
Reasoning documentation, evidence-based practice
Page 2
,Q1. A patient presents with a 3-week history of progressive dysphagia, initially to solids and now to liquids.
There is no heartburn or regurgitation. Barium swallow shows a smooth, tapered narrowing at the
gastroesophageal junction with a 'bird's beak' appearance. Which of the following is the most appropriate
next step in management?
A. Esophageal manometry
B. Upper endoscopy with biopsy
C. Empiric trial of proton pump inhibitor
D. CT scan of chest and abdomen
Correct Answer: A. Esophageal manometry
Rationale: The presentation is classic for achalasia, characterized by failed relaxation of the lower esophageal
sphincter and absent peristalsis. Esophageal manometry is the gold standard for diagnosis. Upper endoscopy is
needed to rule out pseudoachalasia (e.g., from malignancy) but manometry is the next step to confirm. Empiric PPI
is not indicated without evidence of GERD. CT is not diagnostic for achalasia.
Why Wrong:
B - Endoscopy is important to exclude pseudoachalasia but is not the primary diagnostic test for achalasia;
manometry is required for confirmation.
C - Empiric PPI is inappropriate because the presentation is not consistent with GERD; dysphagia without
heartburn suggests a motility disorder.
D - CT may identify extrinsic compression but is not diagnostic for achalasia; manometry is more specific.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 4; UpToDate: Achalasia
Q2. A patient with a history of hypertension and type 2 diabetes is found to have a blood pressure of 148/92
mmHg on three separate occasions. Urine albumin-to-creatinine ratio is 45 mg/g. eGFR is 62 mL/min/1.73
m². Which antihypertensive agent is most likely to provide renal protection and is recommended as first-line
therapy?
A. Hydrochlorothiazide
B. Amlodipine
C. Lisinopril
D. Metoprolol
Correct Answer: C. Lisinopril
Rationale: In patients with chronic kidney disease (eGFR <60) and albuminuria (UACR >30 mg/g), ACE
inhibitors (e.g., lisinopril) or ARBs are recommended to slow progression of nephropathy. Thiazides are less
effective in CKD stage 3. Amlodipine is not renoprotective. Beta-blockers are not first-line for renoprotection.
Why Wrong:
A - Thiazide diuretics become less effective when eGFR is below 30-45 mL/min and do not provide specific
renoprotection.
B - Amlodipine lowers blood pressure but does not reduce proteinuria or slow CKD progression as effectively
as ACEi/ARB.
D - Metoprolol is not first-line for renoprotection; it is indicated for CAD or heart failure.
Reference: KDIGO 2024 Guidelines; ACC/AHA Hypertension Guidelines
Q3. A patient presents with acute onset of severe, tearing chest pain radiating to the back, with a blood
pressure difference of 30 mmHg between arms. Chest X-ray shows a widened mediastinum. What is the most
appropriate immediate diagnostic test?
A. CT angiography of the chest
B. Transthoracic echocardiogram
C. ECG
D. D-dimer
Correct Answer: A. CT angiography of the chest
Page 3
, Rationale: The presentation is classic for acute aortic dissection. CT angiography is the gold standard for rapid diagnosis with
high sensitivity and specificity. TTE may miss ascending dissection. ECG is to rule out MI but not diagnostic. D-dimer has high
sensitivity but is not definitive and may delay definitive imaging.
Why Wrong:
B - TTE is less sensitive for aortic dissection, especially if the dissection is in the descending aorta or if the patient has
poor acoustic windows.
C - ECG is important to assess for ischemia but cannot diagnose dissection; a normal ECG does not rule out dissection.
D - D-dimer has high sensitivity but low specificity; positive result requires confirmatory imaging, causing delay.
Reference: Hiratzka et al. (2010). ACCF/AHA Guidelines for Aortic Dissection
Q4. A patient with a history of opioid use disorder is on methadone maintenance therapy and presents with
acute pain from a fractured femur. Which of the following strategies is most appropriate for pain
management in the perioperative setting?
A. Continue methadone at the same dose and add full-agonist opioids as needed
B. Discontinue methadone and use high-dose short-acting opioids
C. Use only non-opioid analgesics and regional anesthesia
D. Increase methadone dose to cover pain and avoid additional opioids
Correct Answer: A. Continue methadone at the same dose and add full-agonist opioids as needed
Rationale: Methadone should be continued to prevent withdrawal and maintain stability. Additional full-agonist
opioids (e.g., morphine, hydromorphone) are often needed for acute pain due to tolerance. Discontinuing
methadone risks withdrawal and destabilization. Non-opioids alone are insufficient for severe fracture pain.
Increasing methadone is not appropriate as it is long-acting and not titrated for acute pain.
Why Wrong:
B - Abrupt discontinuation of methadone can precipitate withdrawal and increase pain sensitivity; it also
destabilizes recovery.
C - Non-opioid analgesics and regional anesthesia are useful adjuncts but are unlikely to provide adequate
analgesia for acute fracture pain alone.
D - Methadone has a long half-life and is not suitable for acute pain titration; increasing the dose may lead to
accumulation and respiratory depression.
Reference: SAMHSA TIP 63; Chou et al. (2016). Pain Medicine
Q5. A patient with a history of recurrent calcium oxalate kidney stones has a 24-hour urine collection
showing low volume, hyperoxaluria, and hyperuricosuria. Which dietary modification is most likely to
reduce stone recurrence?
A. Increase dietary calcium intake
B. Increase dietary oxalate-rich foods
C. Increase animal protein intake
D. Increase sodium intake
Correct Answer: A. Increase dietary calcium intake
Rationale: Dietary calcium binds oxalate in the gut, reducing oxalate absorption and urinary excretion. Low
calcium intake paradoxically increases oxalate absorption and stone risk. Oxalate-rich foods should be limited.
Animal protein increases uric acid and reduces citrate, promoting stones. Sodium increases calcium excretion.
Why Wrong:
B - Increasing oxalate-rich foods would worsen hyperoxaluria and increase stone risk.
C - Animal protein increases uric acid and decreases urinary citrate, both of which promote stone formation.
D - High sodium intake increases urinary calcium excretion, increasing risk of calcium stones.
Reference: Pearle, M.S. et al. (2024). AUA Guidelines for Medical Management of Kidney Stones
Page 4
